Kezar Life Sciences Inc (KZR) — Cash Flow-to-Debt Ratio
Kezar Life Sciences Inc (KZR) has a Cash Flow-to-Debt Ratio of -2.70x as of March 2026, meaning its operating cash flow of $-7.45 Million could theoretically repay -3% of its total liabilities ($2.76 Million) in one year. Explore Kezar Life Sciences Inc (KZR) cash flow conversion to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kezar Life Sciences Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Kezar Life Sciences Inc across 10 annual periods. Also explore total assets of Kezar Life Sciences Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Kezar Life Sciences Inc (2016–2025)
Year-by-year debt coverage analysis for Kezar Life Sciences Inc. For market capitalisation and broader financial context, see KZR market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -7.88x | $-51.78 Million | $6.57 Million | ▼ -194.7% |
| 2024 | -2.67x | $-74.21 Million | $27.77 Million | ▼ -10.2% |
| 2023 | -2.43x | $-81.64 Million | $33.66 Million | ▼ -22.4% |
| 2022 | -1.98x | $-58.85 Million | $29.70 Million | ▲ +1.7% |
| 2021 | -2.02x | $-42.44 Million | $21.06 Million | ▲ +40.7% |
| 2020 | -3.40x | $-36.95 Million | $10.86 Million | ▼ -30.5% |
| 2019 | -2.61x | $-29.88 Million | $11.47 Million | ▲ +26.3% |
| 2018 | -3.53x | $-20.79 Million | $5.88 Million | ▼ -3381.6% |
| 2017 | -0.10x | $-8.11 Million | $79.91 Million | ▲ +70.0% |
| 2016 | -0.34x | $-9.76 Million | $28.85 Million | — |